Lundbeck
Fredrik Kjaer is an experienced executive in the pharmaceutical industry, currently serving as Vice President of Commercial Planning & Evaluation and Managing Director for Lundbeck Australia & New Zealand since February 2011. With a strong background in global marketing, Fredrik has led the marketing efforts for significant brands in depression and schizophrenia, managing alliances with major partners such as Otsuka and Takeda. Previous roles include Vice President positions for the schizophrenia and depression portfolios, along with key contributions during crucial product launches, including Lundbeck's first global launch of Brintellix. Fredrik's extensive experience is supported by a Master's Degree in Marketing from Mid Sweden University and participation in advanced programs at IMD and London Business School.
This person is not in the org chart
This person is not in any teams
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.